Ischemic stroke
Conditions
Interventions
Treatment group:salvia miltiorrhizae polyphenolic acid injection
Sponsors
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Ischemic stroke (7 days to 3 months, excluding 7 days and including 3 months). 2. NIHSS score from 4 to 20 (including the boundary value). 3. Age 18 and above, regardless of gender. 4. First onset or historical stroke without sequela and mRS score <= 1. 5. Sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Cranial imaging confirmed brain tumor, encephalitis, brain abscess and other diseases with similar symptoms, or confirmed hemorrhagic cerebral infarction, epidural hematoma, intracranial hematoma, ventricular hemorrhage, subarachnoid hemorrhage. 2. Allergic to the drug ingredients used in the study. 3. Patients with severe primary diseases of heart, liver, kidney, blood and endocrine system. 4. Pregnant and lactating women. 5. Drug or alcohol abuser. 6. Mentally ill. 7. Participants who are participating in or have participated in other clinical trials within a month. 8. The researchers did not consider the selected subjects appropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified Rankin Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of apoplexy-related complications;MMSE;NIHSS;Barthel index;The incidence of MACCE; | — |
Countries
China
Contacts
Public ContactXuqiang
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed